Td Asset Management Inc Krystal Biotech, Inc. Transaction History

Td Asset Management Inc

$108 Billion
Q2 2025

A detailed history of Td Asset Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 20,080 shares of KRYS stock, worth $3.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,080

Previous 40,268 50.13%

Holding current value

$3.93 Million

Previous $7.26 Million 61.98%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$123.36 - $181.0 $2.49 Million - $3.65 Million	-20,188 Reduced 50.13%	20,080 $2.76 Million
Q1 2025 May 07, 2025	SELL	$142.64 - $194.44 $458,159 - $624,541	-3,212 Reduced 7.39%	40,268 $7.26 Million
Q4 2024 Feb 11, 2025	BUY	$156.64 - $199.61 $1.57 Million - $2 Million	10,000 Added 29.87%	43,480 $6.81 Million
Q3 2024 Nov 01, 2024	SELL	$174.7 - $213.66 $4.3 Million - $5.26 Million	-24,600 Reduced 42.36%	33,480 $6.09 Million
Q2 2024 Aug 02, 2024	SELL	$153.12 - $183.64 $1.7 Million - $2.04 Million	-11,082 Reduced 16.02%	58,080 $10.7 Million
Q1 2024 May 08, 2024	BUY	$108.01 - $179.35 $3.05 Million - $5.06 Million	28,200 Added 68.84%	69,162 $12.3 Million
Q4 2023 Feb 12, 2024	BUY	$96.0 - $128.29 $1.78 Million - $2.38 Million	18,542 Added 82.7%	40,962 $5.08 Million
Q3 2023 Oct 27, 2023	BUY	$108.51 - $130.22 $717,251 - $860,754	6,610 Added 41.81%	22,420 $2.6 Million
Q2 2023 Aug 09, 2023	BUY	$78.48 - $130.32 $1.24 Million - $2.06 Million	15,810 New	15,810 $1.86 Million
Q4 2020 Feb 16, 2021	SELL	$40.64 - $61.38 $647,070 - $977,292	-15,922 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$37.76 - $48.49 $333,534 - $428,312	-8,833 Reduced 35.68%	15,922 $685,000
Q2 2020 Aug 13, 2020	BUY	$37.03 - $60.0 $148,120 - $240,000	4,000 Added 19.27%	24,755 $1.03 Million
Q1 2020 May 15, 2020	SELL	$35.02 - $65.64 $185,606 - $347,892	-5,300 Reduced 20.34%	20,755 $897,000
Q4 2019 Feb 11, 2020	BUY	$33.17 - $65.23 $19,902 - $39,138	600 Added 2.36%	26,055 $1.44 Million
Q3 2019 Nov 07, 2019	BUY	$34.72 - $51.3 $187,488 - $277,020	5,400 Added 26.93%	25,455 $884,000
Q2 2019 Aug 01, 2019	BUY	$27.2 - $41.2 $323,734 - $490,362	11,902 Added 145.98%	20,055 $808,000
Q1 2019 May 08, 2019	BUY	$19.86 - $32.9 $161,918 - $268,233	8,153 New	8,153 $268,000

Others Institutions Holding KRYS

# of Institutions

314

Shares Held

24.7M

Call Options Held

418K

Put Options Held

485K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.03B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Krystal Biotech, Inc. Transaction History